Molecular diagnosis of invasive mycoses of the central nervous system

References

• Pettit AC, Kropski JA, Castilho JL, et al. The index case for the fungal meningitis outbreak in the United States. N Engl J Med. 2012;367(22):2119–2125.
   PubMed Web of Science ®Google Scholar
• Casadevall A, Pirofski LA. Exserohilum rostratum fungal meningitis associated with methylprednisolone injections. Future Microbiol. 2013;8(2):135–137.
   PubMed Web of Science ®Google Scholar
• McCotter OZ, Smith RM, Westercamp M, et al. Update on multistate outbreak of fungal infections associated with contaminated methylprednisolone injections, 2012-2014. MMWR Morb Mortal Wkly Rep. 2015;64(42):1200–1201.
   PubMed Web of Science ®Google Scholar
• Smith RM, Schaefer MK, Kainer MA, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med. 2013;369(17):1598–1609.
   PubMed Web of Science ®Google Scholar
• Kainer MA, Reagan DR, Nguyen DB, et al. Fungal infections associated with contaminated methylprednisolone in tennessee. N Engl J Med. 2012;367(23):2194–2203.
   PubMed Web of Science ®Google Scholar
• Fowler SB, Carothers B. Fungal infections associated with contaminated methylprednisolone injections: review and insights. N J Nurse. 2013;43(2):12.
   PubMedGoogle Scholar
• Abbas KM, Dorratoltaj N, O’Dell ML, et al. Clinical response, outbreak investigation, and epidemiology of the fungal meningitis epidemic in the United States: systematic review. Disaster Med Public Health Prep. 2016;10(1):145–151.
   PubMed Web of Science ®Google Scholar
• Pappas PG. Lessons learned in the multistate fungal infection outbreak in the United States. Curr Opin Infect Dis. 2013;26(6):545–550.
   PubMed Web of Science ®Google Scholar
• Smith RM, Derado G, Wise M, et al. Estimated deaths and illnesses averted during fungal meningitis outbreak associated with contaminated steroid injections, United States, 2012-2013. Emerg Infect Dis. 2015;21(6):933–940.
   PubMed Web of Science ®Google Scholar
• Stevens DA. Reflections on the approach to treatment of a mycologic disaster. Antimicrob Agents Chemother. 2013;57(4):1567–1572.
   PubMed Web of Science ®Google Scholar
• Kauffman CA, Malani AN. fungal infections associated with contaminated steroid injections. Microbiol Spectr. 2016;4:2.
   Web of Science ®Google Scholar
• Kontoyiannis DP, Perlin DS, Roilides E, et al. What can we learn and what do we need to know amidst the iatrogenic outbreak of exserohilum rostratum meningitis? Clin Infect Dis. 2013;57(6):853–859.
   PubMed Web of Science ®Google Scholar
• Chiller TM, Roy M, Nguyen D, et al. Clinical findings for fungal infections caused by methylprednisolone injections. N Engl J Med. 2013;369(17):1610–1619.
   PubMed Web of Science ®Google Scholar
• Gade L, Grgurich DE, Kerkering TM, et al. Utility of real-time PCR for detection of Exserohilum rostratum in body and tissue fluids during the multistate outbreak of fungal meningitis and other infections. J Clin Microbiol. 2015;53(2):618–625.
   PubMed Web of Science ®Google Scholar
• Panackal AA, Williamson PR. Fungal infections of the central nervous system. Continuum (Minneap Minn). 2015;21(6 Neuroinfectious Disease):1662–1678.
   PubMedGoogle Scholar
• Lahoti S, Berger JR. Iatrogenic fungal infections of central nervous system. Curr Neurol Neurosci Rep. 2013;13(11):399.
   PubMed Web of Science ®Google Scholar
• McCarthy M, Rosengart A, Schuetz AN, et al. Mold infections of the central nervous system. N Engl J Med. 2014;371(2):150–160.
   PubMed Web of Science ®Google Scholar
• Black KE, Baden LR. Fungal infections of the CNS: treatment strategies for the immunocompromised patient. CNS Drugs. 2007;21(4):293–318.
   PubMed Web of Science ®Google Scholar
• Perfect JR. Iatrogenic fungal meningitis: tragedy repeated. Ann Intern Med. 2012;157(11):825–826.
   PubMed Web of Science ®Google Scholar
• Louro R, Ferreira R, Pinheiro C, et al. Fungal meningitis in an immunocompetent patient. Clin Drug Investig. 2013;33(Suppl 1):S47–50.
   PubMed Web of Science ®Google Scholar
• Mattiuzzi G, Giles FJ. Management of intracranial fungal infections in patients with haematological malignancies. Br J Haematol. 2005;131(3):287–300.
   PubMed Web of Science ®Google Scholar
• Scully EP, Baden LR, Katz JT. Fungal brain infections. Curr Opin Neurol. 2008;21(3):347–352.
   PubMed Web of Science ®Google Scholar
• Gavito-Higuera J, Mullins CB, Ramos-Duran L, et al. Fungal infections of the central nervous system: a pictorial review. J Clin Imaging Sci. 2016;6:24.
   PubMed Web of Science ®Google Scholar
• Murthy JM, Sundaram C. Fungal infections of the central nervous system. Handb Clin Neurol. 2014;121:1383–1401.
   PubMedGoogle Scholar
• Soeffker G, Wichmann D, Loderstaedt U, et al. Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis. Prog Transplant. 2013;23(1):71–74.
   PubMed Web of Science ®Google Scholar
• Zunt JR, Marra CM. Cerebrospinal fluid testing for the diagnosis of central nervous system infection. Neurol Clin. 1999;17(4):675–689.
   PubMed Web of Science ®Google Scholar
• Mrazek C, Lass-Flörl C. Biopsy procedures for molecular tissue diagnosis of invasive fungal infections. Curr Infect Dis Rep. 2011;13(6):504–509.
   PubMedGoogle Scholar
• Pazos C, Pontón J, Del Palacio A. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol. 2005;43(1):299–305.
   PubMed Web of Science ®Google Scholar
• Miyazaki T, Kohno S, Mitsutake K, et al. Plasma (1–>3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol. 1995;33(12):3115–3118.
   PubMed Web of Science ®Google Scholar
• Litvintseva AP, Lindsley MD, Gade L, et al. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis. 2014;58(5):622–630.
   PubMed Web of Science ®Google Scholar
• Lyons JL, Thakur KT, Lee R, et al. Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection. J Clin Microbiol. 2015;53(1):319–322.
   PubMed Web of Science ®Google Scholar
• Lyons JL, Roos KL, Marr KA, et al. Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis. J Clin Microbiol. 2013;51(4):1285–1287.
   PubMed Web of Science ®Google Scholar
• Tamura H, Tanaka S, Oda T, et al. Purification and characterization of a (1–>3)-beta-D-glucan-binding protein from horseshoe crab (tachypleus tridentatus) amoebocytes. Carbohydr Res. 1996;295:103–116.
   PubMed Web of Science ®Google Scholar
• Cuétara MS, Alhambra A, Moragues MD, et al. Detection of (1–>3)-beta-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation. Clin Vaccine Immunol. 2009;16(3):423–426.
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis. 2004;39(2):199–205.
   PubMed Web of Science ®Google Scholar
• Petraitiene R, Petraitis V, Hope WW, et al. Cerebrospinal fluid and plasma (1–>3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis. Antimicrob Agents Chemother. 2008;52(11):4121–4129.
   PubMed Web of Science ®Google Scholar
• Mikulska M, Furfaro E, Del Bono V, et al. (1-3)-β-D-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. Clin Infect Dis. 2013;56(10):1511–1512.
   PubMed Web of Science ®Google Scholar
• Malani AN, Singal B, Wheat LJ, et al. (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal meningitis associated with contaminated methylprednisolone injections. J Clin Microbiol. 2015;53(3):799–803.
   PubMed Web of Science ®Google Scholar
• Salvatore CM, Chen TK, Toussi SS, et al. (1 al.orerglucan in cerebrospinal fluid as a biomarker for candida and aspergillus infections of the central nervous system in pediatric patients. J Pediatric Infect Dis Soc. 2016;5(3):277–286.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis. 2008;46(12):1813–1821.
   PubMed Web of Science ®Google Scholar
• Verdaguer V, Walsh TJ, Hope W, et al. Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Rev Mol Diagn. 2007;7(1):21–32.
   PubMed Web of Science ®Google Scholar
• Sulahian A, Tabouret M, Ribaud P, et al. Comparison of an enzyme immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis. 1996;15(2):139–145.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Shoham S, Petraitiene R, et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol. 2004;42(10):4744–4748.
   PubMed Web of Science ®Google Scholar
• Bart-Delabesse E, Basile M, Al Jijakli A, et al. Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments. J Clin Microbiol. 2005;43(10):5214–5220.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Esposto MC, Prigitano A, et al. Cross-reactivity of fusarium spp. in the aspergillus galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol. 2012;50(3):1051–1053.
   PubMed Web of Science ®Google Scholar
• Wheat LJ, Hackett E, Durkin M, et al. Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol. 2007;14(5):638–640.
   PubMed Web of Science ®Google Scholar
• Klont RR, Mennink-Kersten MA, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis. 2004;39(10):1467–1474.
   PubMed Web of Science ®Google Scholar
• Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42(10):1417–1427.
   PubMed Web of Science ®Google Scholar
• Miceli MH, Maertens J. Role of non-culture-based tests, with an emphasis on galactomannan testing for the diagnosis of invasive Aspergillosis. Semin Respir Crit Care Med. 2015;36(5):650–661.
   PubMed Web of Science ®Google Scholar
• Verweij PE, Brinkman K, Kremer HP, et al. Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol. 1999;37(4):1186–1189.
   PubMed Web of Science ®Google Scholar
• Moling O, Lass-Floerl C, Verweij PE, et al. Case reports. chronic and acute Aspergillus meningitis. Mycoses. 2002;45(11–12):504–511.
   PubMed Web of Science ®Google Scholar
• Machetti M, Zotti M, Veroni L, et al. Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole. Transpl Infect Dis. 2000;2(3):140–144.
   PubMedGoogle Scholar
• Chong GM, Maertens JA, Lagrou K, et al. Diagnostic performance of galactomannan antigen testing in cerebrospinal fluid. J Clin Microbiol. 2016;54(2):428–431.
   PubMed Web of Science ®Google Scholar
• Kourbeti IS, Mylonakis E. Fungal central nervous system infections: prevalence and diagnosis. Expert Rev Anti Infect Ther. 2014;12(2):265–273.
   PubMed Web of Science ®Google Scholar
• Badiee P, Alborzi A. Assessment of a real-time PCR method to detect human non-cryptococcal fungal meningitis. Arch Iran Med. 2011;14(6):381–384.
   PubMed Web of Science ®Google Scholar
• Tang MW, Clemons KV, Katzenstein DA, et al. The cryptococcal antigen lateral flow assay: A point-of-care diagnostic at an opportune time. Crit Rev Microbiol. 2016;42(4):634–642.
   PubMed Web of Science ®Google Scholar
• Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57(Suppl 3):S139–70.
   PubMed Web of Science ®Google Scholar
• Sloan DJ, Parris V. Cryptococcal meningitis: epidemiology and therapeutic options. Clin Epidemiol. 2014;6:169–182.
   PubMed Web of Science ®Google Scholar
• Galanis E, Hoang L, Kibsey P, et al. Clinical presentation, diagnosis and management of Cryptococcus gattii cases: lessons learned from British Columbia. Can J Infect Dis Med Microbiol. 2009;20(1):23–28.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Denning DW, Shatsky S, et al. Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications. Mycopathologia. 1999;146(1):1–8.
   PubMed Web of Science ®Google Scholar
• Jackson A. van der Horst C. New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis. Curr HIV/AIDS Rep. 2012;9(3):267–277.
   PubMed Web of Science ®Google Scholar
• Katchanov J, Branding G, Jefferys L, et al. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution. Int J STD AIDS. 2016;27(2):110–117.
   PubMed Web of Science ®Google Scholar
• Powderly WG, Cloud GA, Dismukes WE, et al. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1994;18(5):789–792.
   PubMed Web of Science ®Google Scholar
• Kishi K, Homma S, Nakatani T, et al. [A clinical study of cryptococcal meningitis–sequential changes of cryptococcal antigen titers]. Kansenshogaku Zasshi. 2003;77(3):150–157.
   PubMedGoogle Scholar
• Asawavichienjinda T, Sitthi-Amorn C, Tanyanont V. Serum cyrptococcal antigen: diagnostic value in the diagnosis of AIDS-related cryptococcal meningitis. J Med Assoc Thai. 1999;82(1):65–71.
   PubMedGoogle Scholar
• Micol R, Lortholary O, Sar B, et al. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr. 2007;45(5):555–559.
   PubMed Web of Science ®Google Scholar
• Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol. 1994;32(7):1680–1684.
   PubMed Web of Science ®Google Scholar
• McManus EJ, Jones JM. Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection. J Clin Microbiol. 1985;21(5):681–685.
   PubMed Web of Science ®Google Scholar
• Zerpa R, Huicho L, Guillén A. Modified india ink preparation for Cryptococcus neoformans in cerebrospinal fluid specimens. J Clin Microbiol. 1996;34(9):2290–2291.
   PubMed Web of Science ®Google Scholar
• Dyal J, Akampurira A, Rhein J, et al. Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis. Med Mycol. 2016;54(4):361–369.
   PubMed Web of Science ®Google Scholar
• Vidal JE, Gerhardt J, Peixoto De Miranda EJ, et al. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. Diagn Microbiol Infect Dis. 2012;73(1):68–73.
   PubMed Web of Science ®Google Scholar
• Day JN, Chau TT, Wolbers M, et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med. 2013;368(14):1291–1302.
   PubMed Web of Science ®Google Scholar
• Perfect JR, Bicanic T. Cryptococcosis diagnosis and treatment: what do we know now. Fungal Genet Biol. 2015;78:49–54.
   PubMed Web of Science ®Google Scholar
• Koczula KM, Gallotta A. Lateral flow assays. Essays Biochem. 2016;60(1):111–120.
   PubMed Web of Science ®Google Scholar
• Sharma S, Zapatero-Rodríguez J, Estrela P, et al. Point-of-care diagnostics in low resource settings: present status and future role of microfluidics. Biosensors (Basel). 2015;5(3):577–601.
   PubMedGoogle Scholar
• Fleece ME, Heptinstall J, Khan SS, et al. Evaluation of a Rapid Lateral Flow Point-of-Care Test for Detection of Cryptosporidium. The American Journal of Tropical Medicine and Hygiene. 2016;95(4):840–841.
   PubMedGoogle Scholar
• Campbell JP, Heaney JL, Shemar M, et al. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool. Clin Chem Lab Med. 2016;1(55):100–109.
   Google Scholar
• Hansen J, Slechta ES, Gates-Hollingsworth MA, et al. Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clin Vaccine Immunol. 2013;20(1):52–55.
   PubMed Web of Science ®Google Scholar
• Huang HR, Fan LC, Rajbanshi B, et al. Evaluation of a new cryptococcal antigen lateral flow immunoassay in serum, cerebrospinal fluid and urine for the diagnosis of cryptococcosis: a meta-analysis and systematic review. Plos One. 2015;10(5):e0127117.
   PubMed Web of Science ®Google Scholar
• Chu JH, Feudtner C, Heydon K, et al. Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis. 2006;42(6):822–825.
   PubMed Web of Science ®Google Scholar
• Twarog M, Thompson GR. Coccidioidomycosis: recent updates. Semin Respir Crit Care Med. 2015;36(5):746–755.
   PubMed Web of Science ®Google Scholar
• Hage CA, Azar MM, Bahr N, et al. Histoplasmosis: up-to-date evidence-based approach to diagnosis and management. Semin Respir Crit Care Med. 2015;36(5):729–745.
   PubMed Web of Science ®Google Scholar
• Saccente M. Central nervous system histoplasmosis. Curr Treat Options Neurol. 2008;10(3):161–167.
   PubMed Web of Science ®Google Scholar
• Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20(1):115–132.
   PubMed Web of Science ®Google Scholar
• Kauffman CA. Endemic mycoses: blastomycosis, histoplasmosis, and sporotrichosis. Infect Dis Clin North Am. 2006;20(3):645–62, vii.
   PubMed Web of Science ®Google Scholar
• Swartzentruber S, Rhodes L, Kurkjian K, et al. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis. 2009;49(12):1878–1882.
   PubMed Web of Science ®Google Scholar
• Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011;53(5):448–454.
   PubMed Web of Science ®Google Scholar
• Hage CA, Davis TE, Fuller D, et al. Diagnosis of histoplasmosis by antigen detection in BAL fluid. Chest. 2010;137(3):623–628.
   PubMed Web of Science ®Google Scholar
• Oliveira PB, Abreu MA, Mattos AL. Importance of multidisciplinary approach in diagnosis of histoplasmosis. An Bras Dermatol. 2016;91(3):362–364.
   PubMed Web of Science ®Google Scholar
• Kauffman CA. Histoplasmosis. Clin Chest Med. 2009;30(2):217–225.
   PubMed Web of Science ®Google Scholar
• Tang YW, Li H, Durkin MM, et al. Urine polymerase chain reaction is not as sensitive as urine antigen for the diagnosis of disseminated histoplasmosis. Diagn Microbiol Infect Dis. 2006;54(4):283–287.
   PubMed Web of Science ®Google Scholar
• Babady NE, Buckwalter SP, Hall L, et al. Detection of blastomyces dermatitidis and histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol. 2011;49(9):3204–3208.
   PubMed Web of Science ®Google Scholar
• Thompson G, Wang S, Bercovitch R, et al. Routine CSF analysis in coccidioidomycosis is not required. Plos One. 2013;8(5):e64249.
   PubMed Web of Science ®Google Scholar
• Bamberger DM, Pepito BS, Proia LA, et al. Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosis. Mycoses. 2015;58(10):598–602.
   PubMed Web of Science ®Google Scholar
• Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis. 2006;42(1):103–107.
   PubMed Web of Science ®Google Scholar
• Smith CE, Saito MT, Simons SA. Pattern of 39,500 serologic tests in coccidioidomycosis. J Am Med Assoc. 1956;160(7):546–552.
   PubMed Web of Science ®Google Scholar
• Johnson SM, Pappagianis D. The coccidioidal complement fixation and immunodiffusion-complement fixation antigen is a chitinase. Infect Immun. 1992;60(7):2588–2592.
   PubMed Web of Science ®Google Scholar
• Zartarian M, Peterson EM, De La Maza LM. Detection of antibodies to Coccidioides immitis by enzyme immunoassay. Am J Clin Pathol. 1997;107(2):148–153.
   PubMed Web of Science ®Google Scholar
• Blair JE, Coakley B, Santelli AC, et al. Serologic testing for symptomatic coccidioidomycosis in immunocompetent and immunosuppressed hosts. Mycopathologia. 2006;162(5):317–324.
   PubMed Web of Science ®Google Scholar
• Mathisen G, Shelub A, Truong J, et al. Coccidioidal meningitis: clinical presentation and management in the fluconazole era. Medicine (Baltimore). 2010;89(5):251–284.
   PubMed Web of Science ®Google Scholar
• Galgiani JN, Sun SH, Dugger KO, et al. An arthroconidial-spherule antigen of Coccidioides immitis: differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination. Infect Immun. 1992;60(7):2627–2635.
   PubMed Web of Science ®Google Scholar
• Wieden MA, Lundergan LL, Blum J, et al. Detection of coccidioidal antibodies by 33-kDa spherule antigen, Coccidioides EIA, and standard serologic tests in sera from patients evaluated for coccidioidomycosis. J Infect Dis. 1996;173(5):1273–1277.
   PubMed Web of Science ®Google Scholar
• Vucicevic D, Blair JE, Binnicker MJ, et al. The utility of Coccidioides polymerase chain reaction testing in the clinical setting. Mycopathologia. 2010;170(5):345–351.
   PubMed Web of Science ®Google Scholar
• Binnicker MJ, Popa AS, Catania J, et al. Meningeal coccidioidomycosis diagnosed by real-time polymerase chain reaction analysis of cerebrospinal fluid. Mycopathologia. 2011;171(4):285–289.
   PubMed Web of Science ®Google Scholar
• Schwartz IS, Embil JM, Sharma A, et al. Management and outcomes of acute respiratory distress syndrome caused by blastomycosis: a retrospective case series. Medicine (Baltimore). 2016;95(18):e3538.
   PubMed Web of Science ®Google Scholar
• Stavrakis C, Narayan A, Voronel O. Cerebral blastomycosis: radiologic-pathologic correlation of solitary cns blastomycosis mass-like infection. J Clin Imaging Sci. 2015;5:30.
   PubMedGoogle Scholar
• Wheat LJ. Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis. 2006;8(3):128–139.
   PubMed Web of Science ®Google Scholar
• Brown DA, Whealy MA, Van Gompel JJ, et al. Diagnostic dilemma in primary blastomyces dermatitidis meningitis: role of neurosurgical biopsy. Case Rep Neurol. 2015;7(1):63–70.
   PubMedGoogle Scholar
• Ballesteros A, Beltrán S, Patiño J, et al. [disseminated juvenile paracoccidioidomycosis diagnosed in a girl in an urban area]. Biomedica. 2014;34(1):21–28.
   PubMed Web of Science ®Google Scholar
• San-Blas G, Niño-Vega G, Barreto L, et al. Primers for clinical detection of Paracoccidioides brasiliensis. J Clin Microbiol. 2005;43(8):4255–4257.
   PubMed Web of Science ®Google Scholar
• Rocha-Silva F, Gomes LI, Góes AM, et al. Real Time Polymerase Chain Reaction (rt-PCR): a new patent to diagnostic purposes for paracoccidioidomycosis. Recent Pat Endocr Metab Immune Drug Discov. 2016;11(3):86–98.
   Google Scholar
• Kerkering TM, Grifasi ML, Baffoe-Bonnie AW, et al. Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections. Ann Intern Med. 2013;158(3):154–161.
   PubMed Web of Science ®Google Scholar
• White PL, Barnes RA, Springer J, et al. Clinical performance of aspergillus pcr for testing serum and plasma: a study by the European Aspergillus PCR initiative. J Clin Microbiol. 2015;53(9):2832–2837.
   PubMed Web of Science ®Google Scholar
• Patterson TF, Thompson GR, Denning DW, et al. Executive summary: practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis. 2016;63(4):433–442.
   PubMed Web of Science ®Google Scholar
• Maertens JA, Blennow O, Duarte RF, et al. The current management landscape: aspergillosis. J Antimicrob Chemother. 2016;71(suppl 2):ii23–ii9.
   PubMed Web of Science ®Google Scholar
• Imbert S, Gauthier L, Joly I, et al. Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients. Clin Microbiol Infect. 2016;22(6):562–575.
   PubMed Web of Science ®Google Scholar
• Springer J, White PL, Hamilton S, et al. Comparison of performance characteristics of Aspergillus PCR in testing a range of blood-based samples in accordance with international methodological recommendations. J Clin Microbiol. 2016;54(3):705–711.
   PubMed Web of Science ®Google Scholar
• Reinwald M, Buchheidt D, Hummel M, et al. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. Plos One. 2013;8(2):e56706.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Petraitiene R, Walsh TJ, et al. A real-time PCR assay for rapid detection and quantification of Exserohilum rostratum, a causative pathogen of fungal meningitis associated with injection of contaminated methylprednisolone. J Clin Microbiol. 2013;51(3):1034–1036.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Armeanu E, DiVerniero R, et al. Fungal DNA detected in blood samples of patients who received contaminated methylprednisolone injections reveals increased complexity of causative agents. J Clin Microbiol. 2014;52(6):2212–2215.
   PubMed Web of Science ®Google Scholar
• McCarthy MW, Walsh TJ. PCR methodology and applications for the detection of human fungal pathogens. Expert Rev Mol Diagn. 2016;16(9):1025–1036.
   PubMed Web of Science ®Google Scholar
• Hanson KE. The first fully automated molecular diagnostic panel for meningitis and encephalitis: how well does it perform, and when should it be used? J Clin Microbiol. 2016;54(9):2222–2224.
   PubMed Web of Science ®Google Scholar
• Leber AL, Everhart K, Balada-Llasat JM, et al. Multicenter evaluation of biofire filmarray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54(9):2251–2261.
   PubMed Web of Science ®Google Scholar
• White PL, Parr C, Thornton C, et al. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J Clin Microbiol. 2013;51(5):1510–1516.
   PubMed Web of Science ®Google Scholar
• Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol. 2008;15(7):1095–1105.
   PubMed Web of Science ®Google Scholar
• Prattes J, Flick H, Prüller F, et al. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. Am J Respir Crit Care Med. 2014;190(8):922–929.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Prattes J, Spiess B, et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014;52(6):2039–2045.
   PubMed Web of Science ®Google Scholar
• Johnson GL, Sarker SJ, Nannini F, et al. Aspergillus-specific lateral-flow device and real-time pcr testing of bronchoalveolar lavage fluid: a combination biomarker approach for clinical diagnosis of invasive pulmonary Aspergillosis. J Clin Microbiol. 2015;53(7):2103–2108.
   PubMed Web of Science ®Google Scholar
• Schmidt-Hieber M, Silling G, Schalk E, et al. CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-guidelines of the infectious diseases working party (agiho) of the german society of hematology and medical oncology (DGHO). Ann Oncol. 2016;27(7):1207–1225.
   PubMed Web of Science ®Google Scholar
• Vijayan T, Chiller T, Klausner JD. Sensitivity and specificity of a new cryptococcal antigen lateral flow assay in serum and cerebrospinal fluid. MLO Med Lab Obs. 2013;45(3):16, 8, 20.
   Google Scholar
• Jarvis JN, Percival A, Bauman S, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011;53(10):1019–1023.
   PubMed Web of Science ®Google Scholar
• Boulware DR, Rolfes MA, Rajasingham R, et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg Infect Dis. 2014;20(1):45–53.
   PubMed Web of Science ®Google Scholar
• Arvanitis M, Anagnostou T, Fuchs BB, et al. Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev. 2014;27(3):490–526.
   PubMed Web of Science ®Google Scholar
• Yaman G, Akyar I, Can S. Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures. Diagn Microbiol Infect Dis. 2012;73(1):65–67.
   PubMed Web of Science ®Google Scholar
• Schrödl W, Heydel T, Schwartze VU, et al. Direct analysis and identification of pathogenic lichtheimia species by matrix-assisted laser desorption ionization-time of flight analyzer-mediated mass spectrometry. J Clin Microbiol. 2012;50(2):419–427.
   PubMed Web of Science ®Google Scholar
• Mery A, Sendid B, François N, et al. Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections. Diekema DJ, ed. Journal of Clinical Microbiology. 2016;54(11):2786–2797.
   Google Scholar
• Hanrieder J, Wicher G, Bergquist J, et al. MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue. Anal Bioanal Chem. 2011;401(1):135–147.
   PubMed Web of Science ®Google Scholar
• Ye H, Wang J, Greer T, et al. Visualizing neurotransmitters and metabolites in the central nervous system by high resolution and high accuracy mass spectrometric imaging. ACS Chem Neurosci. 2013;4(7):1049–1056.
   PubMed Web of Science ®Google Scholar
• Neely LA, Audeh M, Phung NA, et al. T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood. Sci Transl Med. 2013;5(182):182ra54.
   PubMed Web of Science ®Google Scholar
• Järvinen AK, Laakso S, Piiparinen P, et al. Rapid identification of bacterial pathogens using a PCR- and microarray-based assay. BMC Microbiol. 2009;9:161.
   PubMed Web of Science ®Google Scholar
• Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–899.
   PubMed Web of Science ®Google Scholar
• Boch T, Spiess B, Cornely OA, et al. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study. Clin Microbiol Infect. 2016;22(10):862–868.
   PubMed Web of Science ®Google Scholar